SMARCB1 and kidney medullary carcinoma: Renal medullary carcinoma (RMC), recently renamed in WHO guidelines as SMARCB1-deficient renal medullary carcinoma, is a rare malignancy that is significantly associated with hemoglobinopathies, particularly sickle cell trait and sickle cell disease [2].